Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
02/23/2006 | US20060040901 Derivatives of 1,3-cyclic propandiol phosphate and their action as cell stimulants |
02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
02/23/2006 | US20060039963 Lipid-analogo phosphoric acid triesters |
02/23/2006 | CA2777473A1 Compounds and methods for the treatment of cancer |
02/23/2006 | CA2577053A1 Phosphonate fluorescent dyes and conjugates |
02/23/2006 | CA2576530A1 Noncardiotoxic pharmaceutical compounds |
02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
02/23/2006 | CA2573765A1 Use of phosphated alcanols as dispersants, emulsifiers, hydrotropes, wetting agents and compatibility agents in agricultural compositions |
02/22/2006 | EP1627868A2 Aspartic ester functional compounds |
02/22/2006 | EP1626952A2 Multifunctional reagent for the synthesis of thiol modified oligomers |
02/22/2006 | EP1626942A1 Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete |
02/22/2006 | EP1626728A2 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
02/22/2006 | EP1539672A4 Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid |
02/22/2006 | EP1423396A4 Synthesis of triphenylphosphonium quinols snd quinones |
02/22/2006 | EP1355912B1 Ligands and their use |
02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
02/22/2006 | CN1738679A Diphosphines, preparation and uses thereof |
02/22/2006 | CN1737005A Chiral diphosphor compound an transition metal complex thereof |
02/22/2006 | CN1737004A Combretastatin compound preparation method |
02/22/2006 | CN1243008C Method for preparing semi-cyclopentadienyl vanadium |
02/22/2006 | CN1243007C Bismuth color reagent of azofluorophosphine-DBF and its synthesis and use |
02/21/2006 | US7002020 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
02/21/2006 | US7002014 [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt; adjusting pH to yield the proper hydrate form |
02/21/2006 | US7001926 Tubulin binding agents and corresponding prodrug constructs |
02/21/2006 | US7001922 Peptide deformylase activated prodrugs |
02/21/2006 | US7001717 Charcoal stabilization of phenyl phosphates |
02/21/2006 | CA2356306C Sulfated phosphatidylinositols, their preparation and use |
02/21/2006 | CA2280938C Lithium fluorophosphates and their use as conducting salts |
02/21/2006 | CA2110443C Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
02/16/2006 | WO2006016079A2 Improved method for making phosphoric acid |
02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
02/16/2006 | US20060036057 Phosphoric ester demulsifier composition |
02/16/2006 | US20060035868 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
02/16/2006 | US20060035863 Noncardiotoxic pharmaceutical compounds |
02/16/2006 | US20060035262 Dark quenchers for donor-acceptor energy transfer |
02/16/2006 | US20060035254 Oligonucleotides comprising a modified or non-natural nucleobase |
02/16/2006 | US20060035113 Lubricant for magnetic recording medium and use thereof |
02/16/2006 | US20060035110 Electroluminescent materials and devices |
02/16/2006 | US20060034773 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
02/16/2006 | DE102004034543A1 Verfahren zur Herstellung von Onium-Salzen mit geringem Chlorid-Gehalt A process for the preparation of onium salts having a low chloride content |
02/16/2006 | CA2576192A1 Synthetically expedient water-dispersible ir dyes |
02/15/2006 | EP1626052A1 Process for production of phosphine-borane complexes |
02/15/2006 | EP1626041A2 New materials useful as electolytic solutes |
02/15/2006 | EP1625168A1 Transition-metal complexes with tridentate, nitrogen-containing ligands |
02/15/2006 | EP1625142A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
02/15/2006 | EP1625134A2 Substituted phosphonate fluorescent sensors and use thereof |
02/15/2006 | EP1625133A2 Nitrogen-containing monodentate phosphines and their use in catalysis |
02/15/2006 | EP1625109A1 Process for the carbonylation of a conjugated diene |
02/15/2006 | EP1268493B1 Phosphoramidate prodrugs |
02/15/2006 | CN1735625A Process for the production of pentaerythritol diphosphonates |
02/15/2006 | CN1735624A Phospholipid derivatives and process for the production there |
02/15/2006 | CN1735588A Synthesis for (R) and (S)-aminocarnitine and derivatives thereof from D-and L-aspartic acid |
02/15/2006 | CN1735342A Small particle copper pyrithione |
02/15/2006 | CN1733967A Precursor compounds for deposition of ceramic and metal films and preparation methods thereof |
02/15/2006 | CN1733782A Dicyclopentadienyl iron pocket ligand possessing central chirality and planar chirality, synthesis method and uses |
02/15/2006 | CN1733779A Novel phosphorus-containing prodrug |
02/15/2006 | CN1733778A Metallic ion modified polyphosphoric acid melamine salt and its preparation method |
02/15/2006 | CN1733777A High purity yolk lecithin preparation method |
02/15/2006 | CN1733776A High purity yolk cephalin preparation method |
02/15/2006 | CN1733775A Method for phosphatide extraction from soybean vegetable oil |
02/14/2006 | US6998500 Halogen-substitited carboxyanilides have the androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor; useful as male contraceptives and hormone replacement therapy |
02/14/2006 | US6998101 Crystallized IM-8 solid of metallophosphate type and process for the preparation thereof |
02/09/2006 | WO2006015261A2 Nucleoside phosphonate conjugates as anti hiv agents |
02/09/2006 | WO2006014282A2 Prodrugs of hiv protease inhibitors |
02/09/2006 | WO2006014006A1 Method for producing unsaturated aminodiols |
02/09/2006 | WO2006013886A1 Novel photosensitive compound and organic thin film formed body |
02/09/2006 | WO2006012952A1 Method for producing phosphate silanes |
02/09/2006 | WO2005108406B1 Bridged bi-aromatic catalysts, complexes, and method of using the same |
02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
02/09/2006 | US20060030738 Device provided with a dedicated dye compound |
02/09/2006 | US20060030737 Lithiating a 1-hydroxy-1-arylalkane, carbonylating with dialkylformamide, and reactng with Grignard reagent; diols may be further reacted with phosphorus compounds to form fused ring dioxaphosphepines; their transition metal complexes and their oxides; fused ring phospholanes; and diphosphinites |
02/09/2006 | US20060030723 Process for synthesis of organometallic compounds |
02/09/2006 | US20060030606 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
02/09/2006 | US20060030605 Pharmaceutical compounds |
02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
02/09/2006 | US20060030546 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
02/09/2006 | US20060030545 Anti-proliferative compounds, compositions, and methods of use thereof |
02/09/2006 | US20060030544 enzyme inhibitors comprising 5-fluoroindole-2-carboxamide compounds, used for the treatment cancer, psoriasis, artherosclerosis, non-insulin depepndent diabetes, obesity and as immunomodulators |
02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
02/09/2006 | CA2571726A1 Prodrugs of hiv protease inhibitors |
02/08/2006 | EP1624016A1 Nanoscalar phosphorous containing fire retardant |
02/08/2006 | EP1623971A1 Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst |
02/08/2006 | EP1622965A1 A method of producing polymeric material |
02/08/2006 | EP1622918A2 Phospholane salts and their use in enantioselective hydrogenation |
02/08/2006 | EP1622917A1 Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents |
02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
02/08/2006 | EP1622860A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
02/08/2006 | EP1622616A2 Inhibitors of akt activity |
02/08/2006 | EP1414463A4 Asymmetric synthesis of kavalactones |
02/08/2006 | EP1404696B1 Activators for oligonucleotide synthesis |
02/08/2006 | EP0937023B2 Process for the preparation of an aldehyde |
02/08/2006 | EP0831869B1 Diphosphonate derivatives of therapeutic agents |
02/08/2006 | CN1732290A Hydrophobic-hydrophilic compounds for treating metallic surfaces |
02/08/2006 | CN1732180A Fluorogenic enzyme substrates and methods of preparation |
02/08/2006 | CN1732176A Process for preparing phosphorodiamidites |
02/08/2006 | CN1732148A Process for preparing nitrile compound from olefinic unsaturated compound |
02/08/2006 | CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
02/08/2006 | CN1731994A Prophylactic and therapeutic agent for neuropathy |
02/08/2006 | CN1730484A Recovery and purification method of hydrogen in exhaust gas of glyphosate acid production |